Promising proteins detected by Western blot from Echinococcus granulosus protoscoleces for predicting early post-surgical outcomes in CE-affected Tunisian children

• Published in: Parasites & vectors Vol. 14; no. 1; p. 180
• Main Authors: Salah, Eya Ben, Barrera, Coralie, Mosbahi, Sana, Gottstein, Bruno, Siles-Lucas, Mar, Belhassen, Samia, Nouri, Abdellatif, Babba, Hamouda, Millon, Laurence, Sakly, Wahiba
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 30.03.2021; BioMed Central; BMC
• Subjects: 2B2t ELISA; Abdomen; Antibodies; Antigens; B2t ELISA; Biomarkers; Care and treatment; Children; Cystic echinococcosis; Cysts; Detection; Diagnosis; Diseases; Echinococcosis; Echinococcus granulosus; Ecology, environment; Evaluation; Fertility; Follow-up; Gel electrophoresis; Health; Immunoblotting; Immunoglobulin G; Immunoreactivity; Life Sciences; Localization; Medical research; Methods; Patients; Pediatrics; Performance prediction; Plasma; Probability theory; Prognosis; Proteins; Protoscolex antigens; Recombinants; Serology; Sodium lauryl sulfate; Surgery; Surgical outcomes; Western blot; Tunisia; Western blot; Cystic echinococcosis; 2B2t ELISA; B2t ELISA; Protoscolex antigens; Follow-up; Post-surgical outcome
• ISSN: 1756-3305; 1756-3305
• DOI: 10.1186/s13071-021-04679-5

Cystic echinococcosis (CE) affects predominantly young patients in highly endemic areas. Improved serological methods are needed for the follow-up of CE cases, especially given the high rates of post-surgical relapse that require detection as soon as possible. We designed a study to investigate the value of antigenic proteins extracted from Echinococcus granulosus (E. granulosus) protoscoleces, and of recombinant B2t and 2B2t proteins, for assessing the efficacy of surgical treatment carried out on CE-affected children. This study was performed on 278 plasma samples collected from 59 Tunisian children surgically treated for CE and monitored for 3 years post-surgery. The patients were classified according to post-surgical outcomes into a "non-relapsed" (NRCE) and a "relapsed" (RCE) group. We performed in-house ELISAs to measure anti-B2t and anti-2B2t IgG and immunoblotting for the detection of IgG against SDS-PAGE-resolved E. granulosus protoscoleces-specific antigens. The Wilcoxon test was applied to assess anti-B2t and anti-2B2t IgG levels. We applied the Cochran Q test to compare the distribution of immunoblotting antigenic bands between 1-month and 1-year post-surgery. The probability of being "relapse-free" when a decrease in antibody titers occurred between 1 month and 1 year post-surgery was 81% and 75%, respectively, for anti-B2t and anti-2B2t IgG. We identified five protoscolex protein bands of 20, 26/27, 30, 40 and 46 kDa as highly immunoreactive by immunoblot for both RCE and NRCE patients at 1 month post-surgery, and significantly lower immunoreactivity after 1 year (p < 10 ) for NRCE compared to RCE patients. The proteins at 26/27 and 40 kDa displayed the best performance in predicting the outcome, with an 84% probability of being relapse-free when the reactivity against the 40 kDa antigen, the doublet at 26/27 kDa, or both was absent or disappeared between 1 month and 1 year post-surgery, and a 93% probability of being relapsed when both bands remained reactive or increased in intensity between the two time points. The B2t protein could be useful for the prediction of CE early post-surgical outcomes. The proteins of E. granulosus protoscoleces, especially the doublet P26/27 and P40, could be promising predictive biomarkers for the post-surgical follow-up of CE cases as well.